News Focus
News Focus
icon url

DewDiligence

10/17/12 3:42 PM

#150787 RE: ghmm #150786

The bad blood had to do with the successor CD20 product.
icon url

masterlongevity

10/17/12 4:28 PM

#150796 RE: ghmm #150786

there have been constant legal and almost leagal battles on Rituxan, ocrelizumab and GA101.

BIIB generally loses each time